Neuropharmacological effects of sigma receptor ligands: Anxiolytic, anti-amnesic and neuroprotective effects

M. Amano, K. Yamada, K. Matsuno, Toshitaka Nabeshima

Research output: Contribution to journalReview article

7 Citations (Scopus)

Abstract

There is evidence for the existence of two classes of sigma binding sites, termed 'site 1' and 'site 2', that are distinct from opioid and PCP receptors. Sigma receptor ligands may be useful in the treatment of schizophrenia, since they improve not only positive but also negative symptoms with little extrapyramidal side effects in animal models. In addition, recent experiments have demonstrated that sigma receptor ligands attenuate the motor suppression and colonic motor disturbances seen under menially stressful situations, stimulate the central cholinergic function thereby ameliorating impairment of learning and memory, and protect cerebral neurons against cerebral ischemic insult. The present review describes the neuropharmacological effects of sigma receptor ligands, especially anxiolytic (anti-stress) effects, ameliorating effects on impairment of learning and memory, and neuroprotective effects.

Original languageEnglish
Pages (from-to)73-84
Number of pages12
JournalJapanese Journal of Psychopharmacology
Volume16
Issue number3
Publication statusPublished - 11-09-1996
Externally publishedYes

Fingerprint

sigma Receptors
Anti-Anxiety Agents
Neuroprotective Agents
Ligands
Phencyclidine Receptors
Learning
Opioid Receptors
Cholinergic Agents
Schizophrenia
Animal Models
Binding Sites
Neurons

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

@article{4b32790df7a242a69bbd52ea8cf7fff1,
title = "Neuropharmacological effects of sigma receptor ligands: Anxiolytic, anti-amnesic and neuroprotective effects",
abstract = "There is evidence for the existence of two classes of sigma binding sites, termed 'site 1' and 'site 2', that are distinct from opioid and PCP receptors. Sigma receptor ligands may be useful in the treatment of schizophrenia, since they improve not only positive but also negative symptoms with little extrapyramidal side effects in animal models. In addition, recent experiments have demonstrated that sigma receptor ligands attenuate the motor suppression and colonic motor disturbances seen under menially stressful situations, stimulate the central cholinergic function thereby ameliorating impairment of learning and memory, and protect cerebral neurons against cerebral ischemic insult. The present review describes the neuropharmacological effects of sigma receptor ligands, especially anxiolytic (anti-stress) effects, ameliorating effects on impairment of learning and memory, and neuroprotective effects.",
author = "M. Amano and K. Yamada and K. Matsuno and Toshitaka Nabeshima",
year = "1996",
month = "9",
day = "11",
language = "English",
volume = "16",
pages = "73--84",
journal = "Neuropsychopharmacology Reports",
issn = "1340-2544",
publisher = "John Wiley and Sons Inc.",
number = "3",

}

Neuropharmacological effects of sigma receptor ligands : Anxiolytic, anti-amnesic and neuroprotective effects. / Amano, M.; Yamada, K.; Matsuno, K.; Nabeshima, Toshitaka.

In: Japanese Journal of Psychopharmacology, Vol. 16, No. 3, 11.09.1996, p. 73-84.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Neuropharmacological effects of sigma receptor ligands

T2 - Anxiolytic, anti-amnesic and neuroprotective effects

AU - Amano, M.

AU - Yamada, K.

AU - Matsuno, K.

AU - Nabeshima, Toshitaka

PY - 1996/9/11

Y1 - 1996/9/11

N2 - There is evidence for the existence of two classes of sigma binding sites, termed 'site 1' and 'site 2', that are distinct from opioid and PCP receptors. Sigma receptor ligands may be useful in the treatment of schizophrenia, since they improve not only positive but also negative symptoms with little extrapyramidal side effects in animal models. In addition, recent experiments have demonstrated that sigma receptor ligands attenuate the motor suppression and colonic motor disturbances seen under menially stressful situations, stimulate the central cholinergic function thereby ameliorating impairment of learning and memory, and protect cerebral neurons against cerebral ischemic insult. The present review describes the neuropharmacological effects of sigma receptor ligands, especially anxiolytic (anti-stress) effects, ameliorating effects on impairment of learning and memory, and neuroprotective effects.

AB - There is evidence for the existence of two classes of sigma binding sites, termed 'site 1' and 'site 2', that are distinct from opioid and PCP receptors. Sigma receptor ligands may be useful in the treatment of schizophrenia, since they improve not only positive but also negative symptoms with little extrapyramidal side effects in animal models. In addition, recent experiments have demonstrated that sigma receptor ligands attenuate the motor suppression and colonic motor disturbances seen under menially stressful situations, stimulate the central cholinergic function thereby ameliorating impairment of learning and memory, and protect cerebral neurons against cerebral ischemic insult. The present review describes the neuropharmacological effects of sigma receptor ligands, especially anxiolytic (anti-stress) effects, ameliorating effects on impairment of learning and memory, and neuroprotective effects.

UR - http://www.scopus.com/inward/record.url?scp=0029848493&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029848493&partnerID=8YFLogxK

M3 - Review article

C2 - 8905794

AN - SCOPUS:0029848493

VL - 16

SP - 73

EP - 84

JO - Neuropsychopharmacology Reports

JF - Neuropsychopharmacology Reports

SN - 1340-2544

IS - 3

ER -